IMARC Group’s report titled “Apheresis Market Report by Component (Plasma (Plasmapheresis), Platelets (Plateletpheresis), Leukocytes (Leukapheresis or Leukopheresis), Lymphocytes (Lymphopheresis or Lymphapheresis), RBC's (Erythropheresis)), Product (Devices, Disposables and Reagents, Software), Technology (Centrifugation, Membrane Separation, Selective Adsorption), Procedure (Donor/Automated Apheresis, Therapeutic Apheresis), Application (Renal Disorders, Hematological Disorders, Neurological Disorders, Autoimmune Disorders, and Others), End User (Blood Centers, Hospitals, and Others), and Region 2024-2032”. The global apheresis market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.59% during 2024-2032.
Grab a sample PDF of this report: https://www.imarcgroup.com/apheresis-market/requestsample
Factors Affecting the Growth of the Apheresis Industry:
- Increasing Prevalence of Chronic Diseases:
Chronic diseases, such as cancer, autoimmune disorders, and blood-related conditions, often require therapeutic interventions that involve removing harmful components from the blood. Apheresis procedures enable the selective removal of these components, thereby helping to manage the symptoms and progression of these diseases. Apheresis techniques are also used for diagnostic purposes in various chronic diseases. Apheresis can also help in analyzing specific blood components or identifying biomarkers associated with certain conditions, aiding in disease diagnosis and monitoring.
- Technological Advancements:
Innovations in apheresis technology are leading to the development of more efficient systems for blood component separation. These advancements enable higher throughput, shorter procedure times, and increased collection yields, enhancing the overall efficiency of apheresis procedures. Modern apheresis machines incorporate sophisticated automation and control features that allow for precise manipulation of blood components. This precision ensures the accurate separation and collection of specific blood components, minimizing the risk of procedural errors and improving patient outcomes.
- Growing Demand for Blood Components:
Apheresis procedures enable the selective collection of specific blood components, such as platelets, plasma, and white blood cells (WBCs). These components have diverse therapeutic applications in transfusion medicine, hematology, oncology, and immunology. Platelets play a crucial role in hemostasis and are frequently needed for patients with bleeding disorders, undergoing surgery, or receiving chemotherapy. Apheresis allows for the efficient collection of platelets from single donors, meeting the high demand for these blood products.
Leading Companies Operating in the Global Apheresis Industry:
- Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation)
- B. Braun SE
- Charles River Laboratories International Inc.
- Fresenius Medical Care AG & Co. KGaA
- Haemonetics Corporation
- Haier Biomedical
- Kaneka Corporation
- Medica S.p.a.
- Miltenyi Biotec
- Nikkiso Co. Ltd.
- Sb-Kawasumi Laboratories Inc. (Sumitomo Bakelite Company Limited)
- Terumo Bct Inc. (Terumo Corporation).
Apheresis Market Report Segmentation:
By Component:
- Plasma (Plasmapheresis)
- Platelets (Plateletpheresis)
- Leukocytes (Leukapheresis or Leukopheresis)
- Lymphocytes (Lymphopheresis or Lymphapheresis)
- RBC's (Erythropheresis)
Plasma (Plasmapheresis) represents the largest segment due to the increasing demand for plasma-derived medications and therapeutic applications in treating a wide range of medical conditions.
By Product:
- Devices
- Disposables and Reagents
- Software
Disposables and reagents account for the majority of the market share owing to their essential role in apheresis procedures, requiring frequent replenishment.
By Technology:
- Centrifugation
- Membrane Separation
- Selective Adsorption
Centrifugation exhibits a clear dominance in the market driven by its widespread adoption, efficiency in separating blood components, and versatility in accommodating various apheresis procedures.
By Procedure:
- Donor/Automated Apheresis
- Therapeutic Apheresis
Donor/automated apheresis holds the biggest market share on account of its efficiency, convenience, and ability to collect specific blood components from donors for therapeutic and transfusion purposes.
By Application:
- Renal Disorders
- Hematological Disorders
- Neurological Disorders
- Autoimmune Disorders
- Others
Hematological disorders hold the biggest market share as apheresis procedures play a critical role in the management and treatment of various hematologic disorders, including leukemia, lymphoma, and aplastic anemia.
By End User:
- Blood Centers
- Hospitals
- Others
Blood centers represent the largest segment. They serve as key facilities for blood collection, processing, and distribution, playing a central role in meeting the demand for blood components derived from apheresis procedures.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys the leading position in the apheresis market, which can be attributed to its well-established healthcare infrastructure, high prevalence of chronic diseases, strong regulatory framework, and extensive adoption of advanced medical technologies.
Global Apheresis Market Trends:
There is a growing emphasis on personalized or precision medicine approaches, which require tailored blood component therapies collected through apheresis procedures to meet individual patient needs. Apheresis procedures are finding expanding therapeutic applications beyond traditional uses, including the treatment of neurological disorders, organ transplantation, and immune-mediated diseases, driving market diversification.
Rising awareness among healthcare professionals and patients about the benefits of apheresis procedures is leading to higher acceptance and utilization of these techniques, contributing to the market growth.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
